Clinical-economic evaluation of distance education and blood glucose level monitoring in adults with diabetes mellitus

Background. Health Technology Assessment (HTA) in the Russian Federation has been performed for drugs, not for other medical technologies, which leads to decision making difficulties today. Aim. This study aimed to assess the clinical and economic efficiency of distance education and monitoring of b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Kachestvennai͡a︡ klinicheskai͡a︡ praktika číslo 4; s. 25 - 39
Hlavní autoři: Omelyanovskiy, V. V., Fediaeva, V. K.
Médium: Journal Article
Jazyk:angličtina
ruština
Vydáno: Izdatelstvo OKI 28.02.2024
Témata:
анализ затраты-эффективность
дистанционное обучение
дистанционный мониторинг
оценка технологий здравоохранения
сахарный диабет
сохранённые годы жизни
школа диабета
ISSN:2588-0519, 2618-8473
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Background. Health Technology Assessment (HTA) in the Russian Federation has been performed for drugs, not for other medical technologies, which leads to decision making difficulties today. Aim. This study aimed to assess the clinical and economic efficiency of distance education and monitoring of blood glucose levels in patients with diabetes mellitus (DM) of both types. Materials and methods. The HTA was prepared using Markov model with a cost-effectiveness analysis methodology. The number of DM complications depending on glycated hemoglobin level with distance education and blood glucose level and without, that has been used for modeling cost of distance education and blood glucose monitoring as well as cost of drugs’ therapy and hospital admission due to DM complications with methodology and source of Obligatory Medical Insurance Fund on 30-yy horizon of modeling. Results. Distance education and blood glucose monitoring in DM patients leads to decrease in complication level as well as mortality, and acceptable additional financial costs from the 5th year of modeling for DM type 1 and from the 6thyear of modeling for type 2 without insulin dose changing. Conclusion. Clinical-economic reasonability of distance education and DM patients’ monitoring are demonstrated in this work. These results should be considered in the decision-making process for HTA budget financing.
ISSN:2588-0519
2618-8473
DOI:10.37489/2588-0519-2023-4-25-39